After months of work, the January issue of the Journal of Commercial Biotechnology, my first as managing editor, has just been published. The links below will take you to each article:
Volume 14, Issue 1
Editorial
| Editorial | |
| Yali Friedman |
Articles
| The ability to pick biotech talent: Being a better interviewer moves ‘you’ up the ladder | |
| David G Jensen |
| How the UN’s anti-biotech policies worsen global warming | |
| Henry I Miller |
| Building a conducive environment for life science-based entrepreneurship and industry clusters | |
| Mark J Ahn, Michael Meeks |
| Cloning an industry: Strategy typologies of Shanghai biotechnology companies | |
| Ken Malone, Brent Hales, Justin Chan, Monica Love, Jeremiah Rayner |
| Biotechnology in India: Public–private partnerships | |
| Viren Konde |
| Biogenerics 2007: How far have we come? | |
| John Tucker, Seth Yakatan, Stan Yakatan |
| Monoclonal antibody therapeutics: Leading companies to maximise sales and market share | |
| Karl Ziegelbauer, David R Light |
| Globalising clinical development in Japan | |
| Yorozu Tabata, Chris Albani |
From the Classroom
| Bioentrepreneurship education programmes in the United States | |
| Arlen D Meyers, Patrick Hurley |
Legal and Regulatory Updates
| Legal and regulatory update | |
| John Wilkinson |